We observed quite significant in-process loss and run-to-run variation: 75–90% of the infectious titre of the product was lost during the lyophilization process, and stability was insufficient for long-term storage in an uncontrolled environment 8 .
← all excerpts
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration.
1
—
—